Loading organizations...
Loading organizations...
Biopharmaceutical company developing therapies for metabolic disorders.
OrsoBio has raised $127.0M across 2 funding rounds.
OrsoBio has raised $127.0M in total across 2 funding rounds.
OrsoBio has raised $127.0M in total across 2 funding rounds.
OrsoBio's investors include Evan Rachlin, Woodline Partners, Enavate Sciences, Marc Galletti.
OrsoBio has raised $127.0M across 2 funding rounds. Most recently, it raised $67.0M Series B in September 2024.
| Date | Round | Lead Investors | Other Investors |
|---|---|---|---|
| Sep 6, 2024 | $67.0M Series B | Evan Rachlin, Woodline Partners | |
| Nov 7, 2023 | $60.0M Series A | Enavate Sciences, Marc Galletti |